Document is current

Any future updates will be listed below

Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing–remitting multiple sclerosis patients and their family members

Crossref DOI link: https://doi.org/10.1038/s41598-022-06322-4

Published Online: 2022-02-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark